Cardiovascular comorbidities in COPD

Thematic Poster
Chairs: J. Marin Trigo (Zaragoza, Spain), S. Centanni (Milano (MI), Italy), D. Sin (Vancouver (BC), Canada)

Influence of concomitant chronic heart failure on incorrect evaluation of chronic obstructive pulmonary disease assessment tests V. Batashova-Halinska (Odesa, Ukraine), L. Kholopov (Odesa, Ukraine), I. Vishnivetskyy (Kiev, Ukraine)
The comparative characteristic of indicators of cardiointervalogram, ergoreflex and 6-MWT in patients with COPD I. Ponomareva (Ryazan, Russian Federation), V. Abrosimov (Ryazan, Russian Federation), A. Kosyakov (Ryazan, Russian Federation), A. Shakhanov (Ryazan, Russian Federation)
Pulmonary hemodynamics and remodeling of the right heart in patients with COPD, depending on the risk group. E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoikhet (Barnaul, Russian Federation), V. Yarkova (Tyumen, Russian Federation), V. Nikitin (Yoshkar-Ola, Russian Federation), A. Denisova (Yoshkar-Ola, Russian Federation)
COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection M. Zambrano Chacon (Madrid, Spain), L. Esteban-Lucía (Madrid, Spain), C. García Talavera (Madrid, Spain), L. Nieto Roca (Madrid, Spain), A. Venegas Rodríguez (Madrid, Spain), R. Fernández Roblas (Madrid, Spain), A. Pello Lázaro (Madrid, Spain), Á. Aceña Navarro (Madrid, Spain), F. Villar Álvarez (Madrid, Spain)
Cardiovascular disease in patients requiring NIV for ECOPD. N. Lane (Newcastle upon Tyne, United Kingdom), T. Hartley (Newcastle upon Tyne, United Kingdom), J. Steer (Newcastle upon Tyne, United Kingdom), M. Elliott (Leeds, United Kingdom), M. Sovani (Nottingham, United Kingdom), H. Curtis (Gateshead, United Kingdom), E. Fuller (South Tyneside, United Kingdom), P. Murphy (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), K. Lewis (Wales, United Kingdom), N. Ward (Plymouth, United Kingdom), C. Turnbull (Oxford, United Kingdom), V. Ferguson (Newcastle upon Tyne, United Kingdom), N. Hart (London, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom)
BODY COMPOSITION ALTERATIONS AND ENDOTHELIAL DYSFUNCTION IN COPD AND HF. F. Salgado Fernández (Taxco, Mexico), D. González Islas (México City, Mexico), A. Orea Tejeda (México City, Mexico), R. Sánchez Santillán (México City, Mexico), A. Flores Vargas (México City, Mexico), A. Jímenez Valentín (México City, Mexico), A. Ibarra Fernández (México City, Mexico), R. Dávila Ramos (México City, Mexico), K. Balderas Muñóz (México City, Mexico), V. Peláez Hernández (México City, Mexico)
The role of prostanoids for stress induced left ventricular diastolic dysfunction in non-severe COPD patients R. Cherneva (Sofia, Bulgaria), Z. Cherneva (Sofia, Bulgaria), P. Sugareva (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria)
The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation E. Tudorache (Timisoara, Romania), O. Fira Mladinescu (Timisoara, Romania), C. Oancea (Timisoara, Romania), N. Porojan Suppini (Timisoara, Romania), B. Timar (Timisoara, Romania), D. Tofolean (Constanta, Romania), A. Fildan (Constanta, Romania)
Relationship between hypoxia and phase angle in COPD and Heart Failure patients D. Gonzalez Islas (Mexico, Mexico), A. Flores Vargas (Mexico, Mexico), R. Sanchez Santillan (Mexico, Mexico), L. Verdeja Vendrell (Mexico, Mexico), A. Ibarra Fernandez (Mexico, Mexico), Y. Piltzi Montiel (Mexico, Mexico), A. Hernandez Lopez (Mexico, Mexico), R. Hernandez Zenteno (Mexico, Mexico), V. Pelaez Hernandez (Mexico, Mexico), K. Balderas Muñoz (Mexico, Mexico)
Correlation between body mass index and spirometry parameters in chronic obstructive pulmonary disease patients with ischemic heart disease and obesity. I. Nemish (Chernivci, Ukraine), G. Stupnytska (Chernivci, Ukraine), O. Fediv (Chernivci, Ukraine), O. Nesterovska (Chernivci, Ukraine)
Assessment of quality of life (QoL) of patients with COPD and with ST-Segment Elevation Myocardial Infarction (STEMI). E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoikhet (Barnaul, Russian Federation), I. Sheremetyeva (Barnaul, Russian Federation), A. Balitskya (Barnaul, Russian Federation)
Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD. E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoykhet (Barnaul, Russian Federation), A. Balitskya (Barnaul, Russian Federation), V. Yarkova (Tyumen, Russian Federation), V. Nikitin (Yoshkar-Ola, Russian Federation)
Pulmonary hypertension in COPD patients: a systematic review and meta-analysis V. Bellou (Ioannina, Greece), L. Belbasis (Ioannina, Greece), K. Kostikas (Ioannina, Greece), I. Tzoulaki (Ioannina, Greece), E. Evangelou (Ioannina, Greece)
Echocardiographic abnormalities in patients with COPD A. Flores Vargas (Mexico, Mexico), R. Sanchez Santillana (Mexico, Mexico), A. Orea Tejeda (Mexico, Mexico), D. Gonzalez Islas (Mexico, Mexico), A. Ibarra Fernandez (Mexico, Mexico), L. Hernandez Urquieta (Mexico, Mexico), K. Balderas Muñoz (Mexico, Mexico), R. Davila Ramos (Mexico, Mexico), A. Jimenez Valentin (Mexico, Mexico), F. Salgado Fernandez (Mexico, Mexico), Y. Pilotzi Montiel (Mexico, Mexico), A. Hernandez Lopez (Mexico, Mexico)
Alterations in water status as risk factor for hospital length stay in COPD and heart failure patientes A. Jiménez Valentín (Mexico City, Mexico), A. Orea Tejeda (Mexico City, Mexico), D. Gonzalez Islas (Mexico City, Mexico), F. Salgado Fernandez (Mexico City, Mexico), R. Davila Ramos (Mexico City, Mexico), A. Lopez Hernandez (Mexico City, Mexico), R. Sanchez Santillán (Mexico City, Mexico), R. Hernandez Zenteno (Mexico City, Mexico), K. Balderas Muñoz (Mexico City, Mexico), V. Pelaez Hernandez (Mexico City, Mexico), A. Ibarra Fernández (Mexico City, Mexico)
Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure. A. Ibarra Fernández (Ciudad de México, Mexico), D. González Islas (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), F. Salgado Fernández (Ciudad de México, Mexico), A. Jiménez Valetín (Ciudad de México, Mexico), A. Flores Vargas (Ciudad de México, Mexico), R. Sánchez Santillán (Ciudad de México, Mexico), R. Davila Ramos (Ciudad de México, Mexico), K. Balderas Muñoz (Ciudad de México, Mexico), V. Peláez Hernández (Ciudad de México, Mexico)
Prevalence of lung function abnormalities in smokers with ischemic heart disease F. Yangui (Tunis, Tunisia), A. Touil (Tunis, Tunisia), S. Antit (Tunis, Tunisia), L. Zakhama (Tunis, Tunisia), S. Ben Youssef (Tunis, Tunisia), M. Charfi (Tunis, Tunisia)
Lung function, blood pressure, and QT duration in a Chinese general population: The Xinxiang rural cohort study X. Zeng (Xinxiang, China), D. Liu (Xinxiang, China), X. Zhao (Xinxiang, China), L. Gui (Xinxiang, China), W. Wu (Xinxiang, China)
Value of peak oxygen pulse for detection of cardiac comorbidities in patients with chronic obstructive pulmonary disease S. Keymel (Duesseldorf, Germany), D. Weber (Duesseldorf, Germany), R. Orzech (Duesseldorf, Germany), S. Krüger (Duesseldorf, Germany)
Prognostic value of Cardiac Troponin I in AECOPD and its impact on mortality R. Jan (Srinagar, India), U. Hafiz (Srinagar, India), S. Irshad (Srinagar, India), T. Hussain (Srinagar, India)